TEVA PHARMACEUTICAL INDUSTRIES LTD
Ticker: 818686
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 4.1K+4.0% | 4.0K-11.1% | 4.5K+7.3% | 4.2K+7.3% | 3.9K-10.2% | 4.3K+4.0% | 4.2K+9.0% | 3.8K |
| Total Income | 4.1K+4.0% | 4.0K-11.1% | 4.5K+7.3% | 4.2K+7.3% | 3.9K-10.2% | 4.3K+4.0% | 4.2K+9.0% | 3.8K |
| EXPENSES | ||||||||
| Expenditure | 4.4K+31.3% | 3.3K-7.4% | 3.6K-3.3% | 3.7K+10.3% | 3.4K-23.1% | 4.4K+5.1% | 4.2K+3.3% | 4.0K |
| Tax | 121.00+80.6% | 67.00-68.7% | 214.00+374.4% | -78.00-205.4% | 74.00+7.2% | 69.00-89.0% | 630.00+1311.5% | -52.00 |
| PROFIT | ||||||||
| PBT | -455.00-204.1% | 437.00-32.4% | 646.00+218.2% | 203.00-31.0% | 294.00+190.7% | -324.00-31.7% | -246.00+47.3% | -467.00 |
| Net Profit | -576.00-256.1% | 369.00-14.8% | 433.00+53.5% | 282.00+31.8% | 214.00+149.0% | -437.00+48.3% | -846.00-508.6% | -139.00 |
| KEY METRICS | ||||||||
| OPM % | -5.58%-21.95pp | 16.37%-3.31pp | 19.69%+8.79pp | 10.90%-2.44pp | 13.34%+14.51pp | -1.18%-1.06pp | -0.12%+5.59pp | -5.71% |
| NPM % | -13.91%-23.17pp | 9.27%-0.40pp | 9.66%+2.91pp | 6.75%+1.25pp | 5.50%+15.59pp | -10.09%+10.23pp | -20.32%-16.68pp | -3.64% |
| EPS | -0.49-253.1% | 0.32-15.8% | 0.38+52.0% | 0.25+31.6% | 0.19+148.7% | -0.39+48.0% | -0.75-525.0% | -0.12 |
Corporate Events
Board MeetingTEVA
202628May
Board Meeting
Annual Meeting of Shareholders to elect a director, approve …
SEC Filing ↗